Applying of radioactive immune quantitative method in evaluation result of treatment I-131 in patients with Basedow’s disease
- Author:
Mai Trong Khoa
- Publication Type:Journal Article
- Keywords:
Basedow
- MeSH:
Graves Disease;
Therapeutics
- From:Journal of Practical Medicine
2005;503(2):59-60
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
175 Basedow’s disease patients (45 males and 170 females; mean age: 44.48 ± 8.89) were treated by I-131 at Bach Mai hospital and Military Hospital 103. Total T3 level in serum was 6.45 ± 2.81 nmol/l (n=146) and total T4 level was 243.58 ± 72.34 nmol/l (n=143). Before treatment T3 and T4 level increased abnormaly comparing with healthy people. By 4 months of treatment, T3 level was 2.15 ± 0.78 nmol/l and T4 level was 120.35 ± 36.81nmol/l, FT4 level was 15.67 ± 6.51pmol/l. With average dose of 6.52 ± 1.64 mCi I-131, most of patients had normalized total T3, T4 level
